Key result
LQTS2, LQTS3, and KCNH2 pore variants linked to major arrhythmic events in childhood-onset LQTS.
Why the study?
Long QT syndrome is associated with sudden cardiac death, and identifying clinical and molecular genetic risk factors for major arrhythmic events in childhood onset LQTS 1–3 was needed.
Does molecular genetic diagnosis contribute to risk stratification for major arrhythmic events in pediatric patients with childhood onset LQTS 1-3?
Cohort (n=101)
Yes
Does molecular genetic diagnosis contribute to risk stratification for major arrhythmic events in pediatric patients with childhood onset LQTS 1-3?
Detailed molecular genetic diagnosis, specifically identifying LQTS2, LQTS3, and KCNH2 pore region variants, provides independent risk stratification for major arrhythmic events in pediatric patients with LQTS.
Answers are grounded in this paper and cite their sources.
May refine pediatric LQTS risk stratification by genotype; hypothesis-generating, needs prospective validation before changing practice.
Long QT syndrome (LQTS) is an inherited arrhythmic disorder associated with sudden cardiac death (SCD). This study aimed to identify the clinical and molecular genetic risk factors that contribute to major arrhythmic events (MAEs) in patients with genetically confirmed childhood onset LQTS 1–3. This study was a retrospective double-center study. An MAE was defined as the occurrence of SCD, aborted SCD, appropriate implantable cardioverter defibrillator discharge, or sustained ventricular tachycardia. During a median follow-up of 4.6 years (range 0.1–24.3 years), MAEs occurred in 18 (17.8%) of 101 patients diagnosed with LQTS at a median of 7.7 years (range 0.0–18.0 years) despite the use of beta-blockers in 91.6% of patients at the last follow-up. A multivariate analysis identified a genetic diagnosis of LQTS2 and LQTS3 and variants within the KCNH2 S5-loop-S6 pore region as independent risk factors for MAEs, independent of the QTc value or a history of syncope detected from a univariate analysis. MAEs occur frequently in childhood onset LQTS despite beta-blocker treatment. A detailed molecular genetic diagnosis can contribute to the arrhythmia risk stratification and optimize the use of preventive measures in this vulnerable patient population.
No takes yet. Share an insight, caveat, or question.
Burkard et al. (2022) conducted a cohort in Childhood onset Long QT Syndrome (LQTS) 1-3 (n=101). Genetic diagnosis of LQTS2, LQTS3, and KCNH2 S5-loop-S6 pore region variants was evaluated on Major arrhythmic events (SCD, aborted SCD, appropriate ICD discharge, or sustained VT). A genetic diagnosis of LQTS2 and LQTS3, and variants within the KCNH2 S5-loop-S6 pore region, were identified as independent risk factors for major arrhythmic events in childhood onset LQTS.
Synapse has enriched 10 related papers. Consider them for comparative context: